Your email has been successfully added to our mailing list.

×
0.0051229508196722 -0.00922131147540982 -0.0133196721311474 -0.0266393442622951 -0.0461065573770491 -0.0368852459016393 -0.0512192622950818 -0.0840061475409835
Stock impact report

Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boosting Regimen Study

Vaxart, Inc (VXRT)  More Company Research Source: GlobeNewswire
Last vaxart, inc earnings: 3/19 04:01 pm Check Earnings Report
PDF Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of U.S. children under age five every year Study results may inform the COVID-19 oral vaccine program SOUTH SAN FRANCISCO, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has enrolled the first subject in a Phase 1b boosting regimen trial of its norovirus vaccine candidate. This study is designed to evaluate the safety and immunogenicity of various dosing intervals for Vaxart’s candidate, which is the only clinical stage norovirus oral tablet vaccine actively being developed. In a health economic study published in the American Journal of Preventative Medicine in January 2021, the negative economic impact to the U.S. of norovirus was estimated to be approx [Read more]
Impact snapshot Event time: VXRT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
VXRT alerts
from News Quantified
Opt-in for
VXRT alerts

from News Quantified
Opt-in for
VXRT alerts

from News Quantified